<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39276957</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-1186</ISSN><JournalIssue CitedMedium="Internet"><Volume>209</Volume><PubDate><Year>2024</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>Pharmacological research</Title><ISOAbbreviation>Pharmacol Res</ISOAbbreviation></Journal><ArticleTitle>Targeting leptin/CCL3-CCL4 axes in NAFLD/MAFLD: A novel role for BPF in counteracting thalamic inflammation and white matter degeneration.</ArticleTitle><Pagination><StartPage>107417</StartPage><MedlinePgn>107417</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.phrs.2024.107417</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1043-6618(24)00362-1</ELocationID><Abstract><AbstractText>Non-alcoholic fatty liver disease (NAFLD), redefined as Metabolic Associated Fatty Liver Disease (MAFLD), is characterized by an extensive multi-organ involvement. MAFLD-induced systemic inflammatory status and peripheral metabolic alteration lead to an impairment of cerebral function. Herein, we investigated a panel of leptin-related inflammatory mediators as predictive biomarkers of neuroinflammation and evaluated the possible role of Bergamot Polyphenolic Fraction (BPF) in counteracting this MAFLD-induced inflammatory cascade. Male DIAMOND mice were randomly assigned to fed chow diet and tap water or high fat diet with sugar water. Starting from week 16, mice were further divided and treated with vehicle or BPF (50 mg/kg/day), via gavage, until week 30. Magnetic resonance imaging was performed at the baseline and at week 30. Correlation and regression analyses were performed to discriminate the altered lipid metabolism in the onset of cerebral alterations. Steatohepatitis led to an increase in leptin levels, resulting in a higher expression of proinflammatory mediators. The inflammatory biomarkers involved in leptin/CCL3-CCL4 axes were correlated with the altered thalamus energetic metabolism and the white matter degeneration. BPF administration restored leptin level, improved glucose and lipid metabolism, and reduced chronic low-grade inflammatory mediators, resulting in a prevention of white matter degeneration, alterations of thalamus metabolism and brain atrophy. The highlighted positive effect of BPF, mediated by the downregulation of the inflammatory biomarkers involved in leptin/CCL3-CCL4 axes, affording novel elements to candidate BPF for the development of a therapeutic strategy aimed at counteracting MAFLD-related brain inflammation.</AbstractText><CopyrightInformation>Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cardamone</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pharmacology Laboratory, Institute of Research for Food Safety and Health IRC-FSH, Department of Health Sciences, University Magna Græcia of Catanzaro, Catanzaro 88100, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coppoletta</LastName><ForeName>Anna Rita</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Pharmacology Laboratory, Institute of Research for Food Safety and Health IRC-FSH, Department of Health Sciences, University Magna Græcia of Catanzaro, Catanzaro 88100, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macrì</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Pharmacology Laboratory, Institute of Research for Food Safety and Health IRC-FSH, Department of Health Sciences, University Magna Græcia of Catanzaro, Catanzaro 88100, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nucera</LastName><ForeName>Saverio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pharmacology Laboratory, Institute of Research for Food Safety and Health IRC-FSH, Department of Health Sciences, University Magna Græcia of Catanzaro, Catanzaro 88100, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruga</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pharmacology Laboratory, Institute of Research for Food Safety and Health IRC-FSH, Department of Health Sciences, University Magna Græcia of Catanzaro, Catanzaro 88100, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scarano</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Pharmacology Laboratory, Institute of Research for Food Safety and Health IRC-FSH, Department of Health Sciences, University Magna Græcia of Catanzaro, Catanzaro 88100, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mollace</LastName><ForeName>Rocco</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Systems Medicine, University of Rome Tor Vergata, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mollace</LastName><ForeName>Annachiara</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pharmacology Laboratory, Institute of Research for Food Safety and Health IRC-FSH, Department of Health Sciences, University Magna Græcia of Catanzaro, Catanzaro 88100, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maurotti</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Experimental and Clinical Medicine, Magna Græcia University, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Micotti</LastName><ForeName>Edoardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carresi</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Veterinary Pharmacology Laboratory, Institute of Research for Food Safety and Health IRC-FSH, Department of Health Sciences, University Magna Græcia of Catanzaro, Catanzaro 88100, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musolino</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Laboratory of Pharmaceutical Biology, Department of Health Sciences, Institute of Research for Food Safety &amp; Health IRC-FSH, University "Magna Græcia" of Catanzaro, Catanzaro, 88100, Italy. Electronic address: v.musolino@unicz.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gliozzi</LastName><ForeName>Micaela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pharmacology Laboratory, Institute of Research for Food Safety and Health IRC-FSH, Department of Health Sciences, University Magna Græcia of Catanzaro, Catanzaro 88100, Italy. Electronic address: gliozzi@unicz.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mollace</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Pharmacology Laboratory, Institute of Research for Food Safety and Health IRC-FSH, Department of Health Sciences, University Magna Græcia of Catanzaro, Catanzaro 88100, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Pharmacol Res</MedlineTA><NlmUniqueID>8907422</NlmUniqueID><ISSNLinking>1043-6618</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adipose tissue inflammation</Keyword><Keyword MajorTopicYN="N">Bergamot polyphenolic fraction (BPF)</Keyword><Keyword MajorTopicYN="N">CCL3/CCL4</Keyword><Keyword MajorTopicYN="N">Cytokines and chemokines</Keyword><Keyword MajorTopicYN="N">Granulocytes</Keyword><Keyword MajorTopicYN="N">Leptin</Keyword><Keyword MajorTopicYN="N">Macrophages</Keyword><Keyword MajorTopicYN="N">Medicinal plants</Keyword><Keyword MajorTopicYN="N">NAFLD/MAFLD/MASLD</Keyword><Keyword MajorTopicYN="N">Natural killers</Keyword><Keyword MajorTopicYN="N">Natural products</Keyword><Keyword MajorTopicYN="N">Thalamus metabolism</Keyword><Keyword MajorTopicYN="N">White matter degeneration</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no competing financial interests that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>15</Day><Hour>14</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>19</Hour><Minute>26</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39276957</ArticleId><ArticleId IdType="doi">10.1016/j.phrs.2024.107417</ArticleId><ArticleId IdType="pii">S1043-6618(24)00362-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle>